Biomedical Research

Objective: The study was on the clinical effect of patients with coronary heart disease complicated with atrial fibrillation after PCI operation.

Methods: 60 cases of patients with coronary heart disease complicated with atrial fibrillation treated in our hospital from March 2015 to March 2016 were chosen, who were divided into treatment group and control group with 30 cases each according to different therapeutic method. The treatment of control group was Hua Falin, and treatment group received aspirin, clopidogrel and Hua Falin for treatment. The clinical effect, incidence and recurrence rate of adverse bleeding events of the two groups were compared.

Results: The treatment effect of treatment group was better than the control group, and there was significant difference between two groups (χ²=4.32, P<0.05), which had statistical significance. The incidence of adverse bleeding events of the treatment group was lower than that of the control group, and there was significant difference between two groups (χ²=4.043, P<0.05). The rate of control group with recurrence was higher than the treatment group, and there was significant difference between two groups (χ²=4.043, P<0.05).

Conclusion: Treating the patients with coronary heart disease complicated with atrial fibrillation by aspirin and clopidogrel after PCI can improve the cure rate and reduce the incidence and recurrence rate of adverse bleeding events. It provides more forceful basis for clinical treatment and has great significance on the treatment of patients with heart disease complicated with atrial fibrillation.

Author(s): Yuan HF, Su XW, Xie XF, Zhang BY, Wang NN, PF Liu, Li TC
Abstract | Full-Text | PDF

Share this